Breaking news
Merck and Moderna say an mRNA vaccine shows promise in preventing the recurrence of melanoma, sending stocks soaring
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
The companies have not published the trial data but said in a press release that the experimental treatment extended the time before cancer returned in high-risk patients.




